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ABSTRACT 
Asthma is a chronic inflammatory disease of the airways affecting hundreds of millions of 
people worldwide. Central to the development of asthma and allergic airway inflammation 
are CD4 T cells, which upon activation through their T cell antigen receptor, differentiate into 
T helper (Th) cells with the potential to secrete distinct sets of cytokines. These cytokines 
have the ability to potentiate or regulate inflammation in all the organs of the body. In 
asthma, Th2 cells that produce IL-4, IL-5 and IL-13, have been heavily implicated in 
promoting pathogenesis in the lung. However, other T helper cell subsets, such as IL-17-
producing Th17 cells may also play a pathogenic role. 
Paper I established that peroxisome proliferator activated receptor gamma (PPAR- was an 
important factor for the differentiation of IL-5- and IL-13-producing Th2 cells in a mouse 
model of allergic airway inflammation with the allergen, house dust mite (HDM). Mice 
lacking PPAR- in T cells did not develop Th2 cell-associated pathologies, including airway 
eosinophilia and goblet cell metaplasia. Further, these mice were unable to mount a protective 
immune response to infection with Heligmosomoides polygyrus. Mechanistically, PPAR- 
appeared to promote the expression of the IL-33 receptor on Th2 cells, which enhanced their 
pathogenic functions. Paper II used single-cell RNA sequencing (scRNA-seq) to resolve 
distinct subsets of T helper cells in the HDM model of asthma. Th2 cells were found to 
differentially express over 100 genes including known Th2 cell genes such as Gata3, Il13, 
Il1rl1 and Pparg (described in paper I) as well as many other genes not previously reported to 
have a specific role in promoting Th2 cell function. Th2 cells were enriched for genes 
associated with lipid metabolism, which when blocked, impaired Th2 cell-driven 
inflammation in the lung tissue and airways. scRNA-seq also resolved a population of Th 
cells responding to type-I interferons. Paper III established a novel mouse model using dog 
allergen extract instillations to induce airway inflammation, which was characterized by a 
mixed Th2/Th17 response. In characterizing this model it demonstrated that dog allergen 
extracts can induce high levels of airway eosinophilia and neutrophilia, airway 
hyperresponsiveness, goblet cell metaplasia and increased serum levels of IgE. scRNA-seq of 
T helper cells from the airways of dog allergen-exposed mice resolved several distinct 
subsets, providing a gene expression signature for responding Th17 cells and providing a 
largely overlapping gene signature for Th2 cells as that which was elucidated in paper II. 
Sublingual immunotherapy using recombinant dog allergens proved successful in 
ameliorating airway eosinophilia and the Th2 cell response to dog allergen challenge, but did 
not affect the Th17 cell response. 
The work presented in this thesis improves our understanding of the factors governing T 
helper cell differentiation and function in the context of allergic airway inflammation. It 
showcases that scRNA-seq is a powerful tool to study diverse T helper cell populations and 
sheds light on genes and cellular processes of relevance to specific subsets. Finally, the novel 
mouse model of dog allergies presents a tool with which to study airway inflammation driven 
both by Th2 and Th17 cells as well as an approach to treat dog allergies. 
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1 INTRODUCTION 
1.1 ASTHMA AND ALLERGIC DISEASE 
More than one billion people are currently affected by allergy and the incidence of allergic 
diseases is rising rapidly, with 4 billion people estimated to be affected by 2050 (Akdis and 
Agache, 2014). One popular explanation for the increase of allergic diseases and asthma is 
the so called “hygiene hypothesis” that postulates that a decrease in exposure to infectious 
organisms have led to the current allergy epidemic (Strachan, 1989). Over the last few years, 
this has come to encompass changes in diet and an altered microbiome as well, which help to 
shape our overall microbial composition (Lambrecht and Hammad, 2017). Over 300 million 
people worldwide suffer from asthma, a chronic inflammatory disease of the airways. Yearly, 
more than 400,000 people are estimated to die from asthma (Network, 2018). Asthma is 
characterized by airway hyperresponsiveness (AHR), airflow obstruction, mucus 
overproduction and airway remodeling. These physiological changes can lead to shortness of 
breath, wheezing and chest tightness. 
 
Many different cell types from both the innate and adaptive immune system as well as 
epithelial cells are involved in the development and pathology of asthma (Lambrecht and 
Hammad, 2012). Chronic inflammation and associated tissue healing induces airway 
remodeling, typified by increased thickness of the basement membrane and lung smooth 
muscle layer, and goblet cell metaplasia (See Fig. 1) (Vignola et al., 2001). The risk to 
develop asthma has been shown to have a strong genetic component, with heritability 
estimated to be as high as 60% based on twin studies (Duffy et al., 1990). Further risk factors 
for the development of asthma include exposure to air pollution and cigarette smoke, obesity, 
infections with respiratory syncytial virus early in life, and exposure to a smaller range of 
microorganisms (Burke et al., 2012; Camargo et al., 1999; Clark et al., 2010; Ege et al., 2011; 
Szabo et al., 2013). Young children lacking a diverse gut microbiota are also at a higher risk 
of developing asthma later in life (Abrahamsson et al., 2014; Sjögren et al., 2009). Acute 
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asthma exacerbations can be caused by a range of triggers including allergens, irritants (such 
as smoke or dust), cold air, exercise and respiratory virus infections (Jackson et al., 2011). 
 
1.1.1 Classifications of asthma 
In 1947, Rackemann proposed that asthma should be segregated into ‘intrinsic’ and 
‘extrinsic’ phenotypes (Rackemann, 1947). ‘Intrinsic’ asthma was associated with a late onset 
of age and associated with a range of co-morbidities including polypoid sinusitis, while 
‘extrinsic’ asthma was associated with rhinitis and bronchiolitis and presented in childhood. 
Later, these terms extrinsic and intrinsic were replaced by ‘allergic’ and ‘non-allergic’ 
respectively, as it became increasingly appreciated that elevated allergen-specific IgE was at 
the heart of ‘allergic asthma’ (Novak and Bieber, 2003). Now, it is appreciated that some 
asthmatics may fall into a third ‘mixed’ group, and that all three forms of asthma entail 
airway inflammation and bronchoconstriction. Hallmarks of allergic asthma include elevated 
serum levels of allergen-specific IgE (Romanet‐Manent et al., 2002), enhanced production of 
Th2 type cytokines (interleukin (IL)-4, IL-5, IL-6, IL-9, IL-10 and IL-13) (Novak and Bieber, 
2003; Yasruel et al., 1997), elevated numbers of cells expressing the high-affinity receptor for 
IgE (FRI) (Humbert et al., 1996), and recruitment of eosinophils (Conti and DiGioacchino, 
2001). Non-allergic asthma has a later onset, a more severe clinical course, no evidence of 
IgE-mediated allergy but also enhanced Th2 type cytokines in the lung parenchyma and 
airways (Humbert et al., 1999; Novak and Bieber, 2003). More recent work suggests to 
further separate patient groups based on mono- and polysensitization to known allergens and 
comorbidities (Anto et al., 2017). 
1.1.2 Allergens 
Allergens are often harmless, environmental antigens, which can lead to sensitization and 
induction of a humoral and cellular immune response. They are commonly proteins and 
glycoproteins and sources can be furry animals, arthropods (for example house dust mites 
(HDM)) or plants. Nomenclature of allergens employ abbreviations of the Latin names 
following the Linnean system and sequential numbers, e.g. Ara h 1 is the major peanut 
(Arachis hypogaea) allergen. Why only a small number of proteins in the environment is able 
to elicit an allergic response is not fully understood, but several allergens have been found to 
share common properties. Many allergen proteins, such as the HDM allergen Der p 1 exhibit 
protease activity which enhances the potential of antigen presentation by degradation of 
epithelial barriers, causes the release of damage associated molecular patterns and by directly 
stimulating epithelial cells to produce proinflammatory cytokines such interleukin- (IL-) 33 
(Jacquet, 2011). Others bind directly to receptors of the innate immune system, thereby 
inducing an immune response. The HDM allergen Der p 2 for example has been shown to 
directly activate TLR2 and TLR4 (Chiou and Lin, 2009; Hammad et al., 2009), whereas the 
cat allergen Fel d 1 enhances TLR2 and TLR4 signaling not through direct binding but by 
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interacting with lipopolysaccharide (LPS). The dog allergen Can f 6 has also been shown to 
bind LPS (Herre et al., 2013). 
HDM allergens are very prominent in society. Dust mites are so prevalent that one study 
found more than 10 µg per gram of carpet dust in close to 80% of houses surveyed 
(Hannaway and Roundy, 1997). In addition to the allergenic properties of HDM, mites also 
contain their own microbiota, which may function as natural adjuvants (Valerio et al., 2005). 
Dermatophagoides pteronysinnus and D. farinae are the main species linked to allergies and 
the most prevalent with 87% and 47% occurrence, respectively (Colloff, 2010). An early 
study revealed that the majority of allergic asthmatics had high levels of IgE to this allergen, 
suggestive of a causative link between HDM and the development of asthma (Sporik et al., 
1990). However, it has come to be observed that sensitization to HDM is very common in 
society (Calderón et al., 2015). Frequent cleaning and good ventilation can reduce the 
concentration of HDM in homes, however the positive effects of such interventions on 
improving asthma symptoms are not very strong and have been subject of debate (Gøtzsche 
and Johansen, 2008; Pingitore and Pinter, 2013). Which could in parts be due to exposure to 
HDM in public places (Tovey et al., 2013). Several HDM allergens show cross reactivity to 
other invertebrates, such as Der p 10 to the shrimp allergen Pen a 1 (Shanti et al., 1993; 
Sidenius et al., 2001). 
Many allergens from furry animals such as the dog allergens Can f 1, 2, 4 and 6, the mouse 
allergen Mus m 1 or the bovine allergen Bos d 2, belong to the lipocalin family. Members of 
this protein family have been shown to bind to human dendritic cells and to promote T helper 
(Th) 2 cell responses (Klaver et al., 2020). Structural similarities between lipocalins from 
different species are thought to be the cause of multi-sensitization commonly found in 
allergic patients (Nilsson et al., 2014b). Other pet allergens belong to the serum albumin, 
kallikrein, latherin and secretoglobin protein families (Curin and Hilger, 2017). Can f 1, a 
lipocalin, and Can f 5, a prostatic kallikrein, are major dog allergens to which up to 70% of 
dog allergic patients are sensitized (Curin and Hilger, 2017; Mattsson et al., 2009). Can f 2 
and Can f 4 are also lipocalins and Can f 3 is a serum albumin. These are considered minor 
dog allergens with sensitization rates between 23 and 35% of dog-allergic individuals (Curin 
and Hilger, 2017) .Cross-reactivity is not only seen between different types of aeroallergens 
but also between aeroallergens and food allergens, such as birch-apple or mite-shrimp. This is 
mostly seen in adults following sensitization with cross-reactive aeroallergens (Popescu, 
2015). 
1.2 TREATMENT OF ASTHMA 
Common treatments for asthma are bronchodilators and corticosteroids, which ameliorate 
airway constriction and inflammation. Patients with mild asthma can often be treated with 
inhaled adrenergic 2 receptor agonists (bronchodilator) (Alangari, 2014). While treatment is 
effective and safe in most patients, these drugs can cause severe side effects and an estimated 
10% of patients do not respond to common treatment options (Dahl, 2006; Olin and 
Wechsler, 2014). While only a minority of patients show a poor response to treatment, the 
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costs of treating these patients are incredibly high (Breekveldt-Postma et al., 2008). It is 
increasingly appreciated that these common treatments may perform better in certain forms of 
asthma over others. For instance, childhood-onset asthma appears to be quite responsive to 
standard therapies, while a greater proportion of people with adult-onset asthma appear 
insensitive to these therapies (Lang et al., 2008; Wenzel, 2012). 
1.2.1 Corticosteroid treatment 
Corticosteroids have been used in asthma treatment since 1956 (Christie et al., 1956). 
Corticosteroids ameliorate asthmatic disease by exerting an anti-inflammatory effect on a 
range of target cells, including eosinophils, T cells, mast cells and epithelial cells (Barnes and 
Adcock, 2003). Corticosteroid treatment reduces the amount of airway infiltrating 
inflammatory cells and reduces AHR (Barnes, 1996). Corticosteroids bind to the 
glucocorticoid receptor (GR) in the cytoplasm, triggering the release of chaperone proteins 
and exposing nuclear translocation signals (Grad and Picard, 2007). In the nucleus GR binds 
to glucocorticoid response elements in DNA which leads to the regulation of gene expression 
and down regulation in transcription mediated by activator protein-1 (AP-1) and nuclear 
factor-B (NF-B) (Barnes, 2001). Corticosteroids also promote the expression of anti-
inflammatory genes encoding IL-10 (John et al., 1998) and 2-adrenoceptors (Baraniuk et al., 
1997). Steroid resistant airway inflammation has been associated with Th17 cells, 
antimicrobial activated airway macrophages and reduced IL-10 production (Goleva et al., 
2008; Hawrylowicz et al., 2002; McKinley et al., 2008). Neutrophils are less sensitive to the 
effects of corticosteroids, including resistance to corticosteroid induced apoptosis (Liles et al., 
1995). The induction of anti-inflammatory genes in neutrophils by corticosteroids is 
counteracted by the simultaneous induction of pro-inflammatory genes (Ronchetti et al., 
2018). Thus, it is perhaps not surprising that neutrophilic asthma has been associated with 
steroid resistance (Poon et al., 2012).  
1.3 THE ROLE OF THE IMMUNE SYSTEM IN ALLERGIC DISEASE 
Airway epithelial cells are among the first cells to come in contact with inhaled allergens. 
They express various pattern recognition receptors, such as Toll-like receptor (TLR4), which 
can be triggered by allergens (Salazar and Ghaemmaghami, 2013). After activation, epithelial 
cells secrete multiple cytokines and chemokines, including IL-25, IL-33, thymic stromal 
lymphopoietin (TSLP) and granulocyte-macrophage colony stimulating factor (GM-CSF), 
which trigger receptors on various innate cells including dendritic cells (DC) (Lambrecht and 
Hammad, 2012). Pulmonary DC, which encounter and acquire allergens upon inhalation also 
express pattern recognition receptors and can act as antigen presenting cells. Additional DC 
are recruited to the airway through signals from the epithelium upon allergen exposure 
(Pichavant et al., 2005; Plantinga et al., 2013). Antigen-loaded DC migrate to the lung 
draining lymph node where they affect the differentiation of CD4 T helper cells into different 
subsets (Lambrecht and Hammad, 2009; Maazi et al., 2013; Otero et al., 2010). Figure 2 
gives a schematic overview over the development of an immune response to allergen 
exposure in the airways. 
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1.3.1 T cells 
T lymphocytes, expressing a T cell antigen receptor (TCR) have been heavily implicated in 
the development of asthma and other allergies (Betts and Kemeny, 2009; Corrigan and Kay, 
1992). Conventional T cells recognize peptides presented in the context of major 
histocompatibility molecules (MHC), which are known as human leukocyte antigens (HLA) 
in humans. Two major forms of MHC molecules present peptide antigens to T cells; MHC-I 
and MHC-II, which present antigens to CD8
+
 T and CD4
+
 T cells, respectively (Germain, 
2002).  
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T cell development first requires the migration of lymphoid progenitor cells from the bone 
marrow to the thymus. At this stage lymphoid precursors do not express CD3 molecule 
family members, which are co-receptors for the TCR, nor the antigens CD4 and CD8. Thus, 
they were termed triple negative cells (Godfrey et al., 1993), a nomenclature subsequently 
revised to double negative (DN, CD4-CD8-) cells. Double negative cell differentiation 
proceeds through DN1 to DN4 based on the expression of the IL-2 receptor alpha subunit 
(CD25) and CD44. During this early stage, a pre-TCR alpha chain is expressed in 
combination with a successfully rearranged TCR beta chain, forming the pre-TCR. In a 
process known as beta-selection in the thymic cortex, signaling through the pre-TCR induces 
proliferation, expression of both CD4 and CD8 (double positive, DP), the rearrangement of 
the -chain and suppresses further rearrangement of the -chain (Krangel, 2009; Murphy and 
Weaver, 2016). In the process of positive selection, DP cells are thereafter tested for their 
reactivity to MHC-I and MHC-II molecules expressed on cortical epithelial cells. T cells 
successfully recognizing peptide in the context of MHC-II in T cells, lose their expression of 
CD8 becoming CD4 T cells, while those selected on MHC-I lose CD4 and become CD8 T 
cells. Only a fraction of double positive T cells make it through positive selection (Germain, 
2002; Taniuchi, 2018). The CD4 lineage is solidified through signals received through the 
TCR inducing the expression of the transcription factors GATA3 and ThPOK (He et al., 
2009), while CD8 T cells rely on the expression of Runx3 to consolidate their fate. Following 
positive selection, cells upregulate expression of CCR7 leading to their migration from the 
cortex to the medulla (Ueno et al., 2004). While positive selection produces T cells able to 
bind antigen, negative selection is required to prevent the development of autoreactive T cells 
in order to protect the body from potentially devastating effects. Cells with a high specificity 
for self-antigens are either removed by apoptosis or appear to differentiate into natural 
regulatory T cells (nTreg) (Josefowicz and Rudensky, 2009), considered the suppressive cells 
of the immune system.  
Naïve T cells leave the thymus to patrol the periphery. They are activated upon encountering 
a cognate peptide antigen presented by professional antigen presenting cells (APC), such as 
DC. Full T cell activation requires the recognition of a peptide antigen in the context of 
MHC-I or MHC-II as well as co-stimulatory signals through receptors including CD28 and 
CD27, which act to facilitate TCR-mediated signals, promote proliferation, survival and 
impact on the transcriptional profile of cells (Chen and Flies, 2013; Coquet et al., 2015a; 
Tripathi and Lahesmaa, 2014). Upon activation, CD8 T cells differentiate into cytotoxic T 
cells and mediate killing of virus-infected or cancerous cells in a peptide-specific manner. 
CD4 T cells differentiate into T helper cells, which provide help to CD8 T cells and B cells, 
and have a profound ability to potentiate and regulate immune responses via the secretion of 
cytokines.  
T helper cells have been found to differentiate into subsets with distinct cytokine-producing 
potentials and functions. Their differentiation is defined by so-called ‘master regulators’ of 
transcription and typically, on signals received through cytokine receptors, which activate the 
signal transducer and activator of transcription (STAT) family members, janus kinases 
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(JAKs) and Smad proteins (Murphy and Weaver, 2016). Figure 3 provides an overview of the 
differentiation of several known Th cell subsets. Naïve CD4 T cells exposed to IL-12 
differentiate into Th1 cells under the control of STAT1, STAT4 and T-bet and produce 
interferon gamma (IFN-). Th2 cells differentiate following signals through the IL-4 receptor, 
which induces activation of STAT6 and the transcription factor, GATA 3. The cytokines 
produced by Th2 cells are IL-4, IL-5 and IL-13. Differentiation of Th17 cells requires TGF- 
and IL-6, which trigger the expression of STAT3 and retinoic acid receptor-related orphan 
receptor gamma (RORt). Th17 cells also benefit from IL-21 and IL-23 and secrete IL-17. 
Follicular T helper (Tfh) cells produce IL-21 and require costimulatory molecules such as 
CD40 and ICOS to induce expression of Bcl6 and STAT3. And regulatory T cells (Treg) can 
be induced from naïve CD4 T cells by TGF-, which induces activation of Smad3 and 
expression of Foxp3. Treg cells ameliorate inflammation through the expression of IL-10 and 
TGF-(Murphy and Weaver, 2016). Research is ongoing to define distinct novel subsets as 
well as subpopulations within established subsets.  
 
T cells are incredibly important for the control of viruses, cancers, bacteria, and increasingly 
implicated in the promoting organismal health. The importance of CD4 T cells to our general 
health can be seen in the setting of acquired immune deficiency syndrome (AIDS), where 
HIV infects and depletes CD4 T cells (Fanales-Belasio et al., 2010). Intriguingly, there is also 
a growing appreciation that CD4 and CD8 T cells play a role in inflammatory disorders such 
as inflammatory bowel disease, and in autoimmune diseases and allergies. In psoriasis for 
example, Genome wide association studies (GWAS) have repeatedly shown a strong 
association for single nucleotide polymorphisms (SNPs) in HLA-C, implicating a role for 
CD8 T cells in disease (Feng et al., 2009; Strange et al., 2010). SNPs at the HLA-D locus, 
encoding for MHC-II, have been shown to be involved in the pathogenesis of asthma (Li et 
al., 2010; Michel et al., 2010; Moffatt et al., 2010). These findings have been validated 
repeatedly in clinical and preclinical studies, such that T helper cells are seen as a central 
player in the development of asthma.  
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1.3.2 Th2 cells  
Th2 cells were first described by Mosmann and Coffman over thirty years ago (Mosmann et 
al., 1986). They are characterized by the expression of effector cytokines IL-4, IL-5 and IL-
13 and their development is controlled by the lineage defining transcription factors GATA3 
and STAT6 (Kaplan et al., 1996a; Walker and McKenzie, 2018; Zheng and Flavell, 1997). 
Th2 cells support the protective immune response against large parasites and venoms (Galli et 
al., 2016; Paul and Zhu, 2010), but are also central in several allergic disorders including 
asthma (Lambrecht and Hammad, 2015). Naïve T helper cells exposed to IL-4 activate 
STAT6 through signaling via the IL-4 receptor (IL-4R) and JAK1/3 (Kaplan et al., 1996a). 
STAT6 then induces expression of the “master regulator” of Th2 cell differentiation, 
GATA3. Conditional deletion of GATA3 prevents differentiation of Th2 cells (Pai et al., 
2004; Zhu et al., 2004) whereas forced expression induces committed Th1 cells or cells 
lacking STAT6 to produce IL-4 (Lee et al., 2000; Ouyang et al., 2000). GATA3 expression 
induces changes in the chromatin landscape across the Il4/Il13/Rad50/Il5 locus leading to IL-
4 production, which creates a positive feedback loop stabilizing Th2 cell identity (Ansel et 
al., 2006). GATA3 also promotes expression of characteristic surface markers of Th2 cells 
such as Il1rl1 (ST2 subunit of IL-33R) (Nawijn et al., 2001) and the chemokine receptor 
Ccr8 (Wei et al., 2011). Aside from the factors described here, many others could play a role 
in the differentiation and function of Th2 cells. This is a field of ongoing research. 
1.3.3 Th2 cells – the main protagonist in asthma 
Th2 cells are most intimately linked with the development of asthma. Repeatedly, GWAS 
analysis has identified not only SNPs in HLA-D as a major determinant of the risk of 
developing asthma, but also several canonical Th2 cell-associated genes including GATA3, 
IL4, IL5, IL1RL1, IL18R1, RORA, IL33 (Li et al., 2010; Michel et al., 2010; Moffatt et al., 
2010). Furthermore, following bronchoalveolar lavage of patients with asthma, clear 
increases in Th2 cells and their associated cytokines have been observed (Parronchi et al., 
1991; Robinson et al., 1992). These clinical associations have been corroborated by many 
studies in preclinical models of allergy and asthma (Gavett et al., 1994; Gavett et al., 1995; 
Nakajima et al., 1992). IL-4 has been shown in mouse models to be required for the B cell 
switch to IgE antibody production (Del Prete et al., 1988). IL-13 is required for AHR in Th2 
cell driven models of asthma (Wills-Karp et al., 1998). Blocking of IL-13 in mouse models of 
allergic airway inflammation reduced AHR, mucus production and airway eosinophilia 
(Grünig et al., 1998). Trials blocking IL-13 or signaling downstream of IL-4 and IL-13 in 
patients with severe asthma have successfully improved lung function of patients (Corren et 
al., 2011; Wenzel et al., 2013), demonstrating the causative role of Th2 cells in asthmatic 
disease. IL-5 appears to primarily support differentiation, proliferation and survival of 
eosinophils (Yamaguchi et al., 1988a; Yamaguchi et al., 1988b) and a meta-analysis of IL-5 
blockade in humans shows a reduction in exacerbations by 40% (Cabon et al., 2017). 
  9 
1.3.4 Other T helper cell subsets:  
Though Th2 cells are the main T helper cell subset implicated in allergy, roles for Th1, Th17, 
Treg, Tfh, and CD8 T cells have also been postulated, either in combination with Th2 cells or 
in types of asthma lacking Th2 cells. 
1.3.5 Th1 cells 
Th1 cells are characterized by their secretion of IFN- as well as IL-2 and tumor necrosis 
factor (TNF and are protective against intracellular pathogens (Romagnani, 1999). Th1 cells 
require IL-12 signaling to differentiate, which signals through STAT-1 and STAT-4 to induce 
T-bet and IFN- production (Jacobson et al., 1995; Kaplan et al., 1996b; Szabo et al., 2000). 
The secretion of IFN- by Th1 cells induces the production IL-12 by antigen presenting cells, 
thereby creating a positive feedback loop and inhibiting Th2 cell differentiation (Abbas et al., 
1996). Th1 cells and IFN- are known to counteract the differentiation of Th2 cells and may 
be protective in the context of asthma since administration of IL-12 or IL-18 ameliorates Th2 
cell-driven symptoms (Gavett et al., 1995; Hofstra et al., 1998). However, studies have 
revealed a more complex and less beneficial role of Th1 cells in the context of asthma. Th1 
cells are able to induce AHR (Cui et al., 2005) and allergen-specific Th1 cells fail to control 
Th2 responses and lead to high levels of airway inflammation (Hansen et al., 1999). This is 
supported by the detection of increased levels of IFN- in the airways of asthmatic patients 
(Krug et al., 1996). 
1.3.6 Th17 cells 
Th17 cells secrete IL-17, IL-17F and IL-22 (Alcorn et al., 2010). They develop from naïve 
CD4 T helper cells stimulated with TGF-, IL-6, IL-1 and IL-23 which leads to the 
activation of STAT-3 and expression of RORt (Bettelli et al., 2006; Korn et al., 2009). 
Binding of IL-17 to IL-17R on epithelial cells induces secretion of the neutrophil chemokine 
CXCL8 (Korn et al., 2009). In asthma, IL-17 levels in patient sputum correlate with increased 
neutrophil numbers and increased AHR following methacholine challenge (Alcorn et al., 
2010; Barczyk et al., 2003). IL-17 stimulation of epithelial cells further leads to increased 
expression of Mucin 5AC and goblet cell metaplasia (Fujisawa et al., 2009; Hashimoto et al., 
2005) and has a direct effect on smooth muscle cells, inducing hyperresponsiveness (Chiba et 
al., 2017; Kudo et al., 2012). Cells producing both Th2 and Th17 cytokines have been 
reported in atopic asthma patients and in mouse model using OVA, leading to a diverse influx 
of inflammatory cells (Wang et al., 2010). It has also been proposed that diesel exhaust 
particles may induce IL-17 production in the HDM model of asthma in mice (Brandt et al., 
2013).  
1.3.7 Th9 cells – A variant of Th2 cells?  
IL-9 has been found in the airways of patients with atopic asthma and is upregulated upon 
allergen exposure (Erpenbeck et al., 2003). IL-9 producing Th9 cells were originally thought 
to be a subset of Th2 cells, given its positive association to allergic disease. Studies have also 
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suggested that Th9 cells may represent a functionally-distinct T helper cell subset (Schmitt 
and Bopp, 2017; Veldhoen et al., 2008), however recent analyses have suggested once again 
that IL-9 production is specific to cells expressing high levels of IL-5 and IL-13 (Micossé et 
al., 2019). The differentiation of IL-9-secreting cells requires both IL-4 and TGF- (Schmitt 
et al., 1994). Transfer of in vitro generated Th9 cells to naïve mice induces airway 
eosinophilia, increased numbers of mast cells and raised serum IgE levels (Jones et al., 2012). 
IL-9 signaling through the IL-9R affects a range of cells and processes relevant to the 
development of asthma. It suppresses Th1 cell immune responses (Wu et al., 2008), promotes 
mast cell proliferation and airway remodeling (Kearley et al., 2011) and enhances survival, 
differentiation and expression of the IL-5 receptor on eosinophils (Gounni et al., 2000). IL-9 
may also be produced by other T cell subsets, mast cells and ILC2 (Koch et al., 2017).  
1.3.8 Follicular helper T cells 
Follicular helper T (Tfh) cells are essential for the formation of germinal centers (GC) and 
affinity maturation of antibodies produced by B cells (Crotty, 2014). The transcription factor 
Bcl6 is the master regulator of Tfh cell differentiation (Johnston et al., 2009; Nurieva et al., 
2009; Yu et al., 2009) and the cytokine IL-21 is a hallmark of Tfh cells (Chtanova et al., 
2004). IL-6 induces transient expression of Bcl6 by signaling through the IL-6 receptor 
(Nurieva et al., 2009) and is thought to be important for Tfh cell differentiation. Development 
of Tfh cells further requires inducible costimulator (ICOS) signaling during priming by DC. 
This induces Bcl6, which in turn induces CXCR5 (Choi et al., 2011). This first stage of Tfh 
cell development is not sufficient for full Tfh effector function, since Tfh cells in the absence 
of additional antigen presenting cells besides DC fail to produce the key cytokine IL-21 
(Goenka et al., 2011). Expression of the chemokine receptor CXCR5 leads to colocalization 
with B cells, which provide ICOS ligand and present antigen to the Tfh cell (Crotty, 2014). 
Down regulation of the Epstein-Barr virus-induced G protein coupled receptor 2 (EBI2) on B 
and Tfh cells facilitates their localization to the germinal center (Hannedouche et al., 2011). 
IL-21 secretion by Tfh cells in the GC promotes proliferation of B cells, affinity maturation 
and differentiation to memory B cells (Zotos et al., 2010). Higher frequencies of Tfh cells 
produce IL-4 in the lymph node compared to Th2 cells (King and Mohrs, 2009; Reinhardt et 
al., 2009). IL-21 is required for the development of Th2 but not for Th17 cell responses 
( r hlich et al., 2007  Sonderegger et al., 2008). Mice sensitized and challenged with HDM 
develop IL-21-producing Tfh cells in the mediastinal lymph node but CXCR5
-
 IL-21
+
 cells 
are also present in the lungs, which promote the Th2 cell response to inhaled allergens 
(Coquet et al., 2015b). IL-21 has also been shown to inhibit suppressive Treg cell responses 
by promoting apoptosis of Treg cells (Tortola et al., 2019). It has been a point of contention 
whether IL-4-producing Tfh cells are precursors of Th2 effector cells as some studies have 
suggested (Ballesteros-Tato et al., 2016). 
1.3.9 Regulatory T cells 
Regulatory T (Treg) cells play an important role in dampening immune responses through the 
secretion of IL-10, CTLA-4 and TGF (Rudensky, 2011; Sakaguchi et al., 2008). The 
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transcription factor Foxp3 is the master regulator of Treg cell development (Fontenot et al., 
2003; Hori et al., 2003; Khattri et al., 2003). CD4 T cells can commit to the Treg cell lineage 
early in their development in the thymus or can be induced from naïve CD4 T cells in the 
periphery (Feuerer et al., 2009). Mice lacking Treg cells only survive for a few months before 
succumbing to autoimmune disease (Brunkow et al., 2001). Adoptive transfer experiments 
have shown that regulatory T (Treg) cells are able to suppress asthma through secretion of the 
cytokines IL-10 and TGF- (Lewkowich et al., 2005). Treg cells also constitutively express 
the inhibitory receptor CTLA-4 (Sansom and Walker, 2006). Several SNPs in the CTLA-4 
gene have been identified to be associated with serum IgE levels and reduced lung function 
(Munthe-Kaas et al., 2004). Some studies have reported on elevated Treg cell numbers in the 
lungs of asthmatic patients (Smyth et al., 2010). Whereas others have shown Treg cell 
numbers in the blood of severe asthmatic patients to be reduced and their suppressive 
capabilities impaired (Mamessier et al., 2008). A subset of Treg cells expressing TIGIT has 
been identified that is able to suppress Th1 and Th17 cells but not Th2 cells (Joller et al., 
2014). 
1.3.10 CD8 T cells  
CD8 T cells are activated upon antigen recognition in the context of MHC-I to become 
cytotoxic effector cells that eliminate infected cells and cancers (Murphy and Weaver, 2016; 
Zinkernagel and Doherty, 1974). Subsets of CD8 T cells expressing similar cytokine profiles 
as Th1, Th2, Th9 and Th17 cells have been described. They are known as Tc1, Tc2, Tc9 and 
Tc17 and are characterized by the expression of IFN-, IL-4, IL-9 and IL-17 respectively 
(Baraldo et al., 2016; Betts and Kemeny, 2009; Srenathan et al., 2016). While the role of CD4 
T cells in asthma has been extensively studied, less is known about CD8 T cells in the context 
of allergic lung inflammation. While some studies have suggested a protective role (Noble et 
al., 2016), others have claimed that CD8 T cell involvement is irrelevant to asthma (Ali et al., 
2007), and yet others have found CD8 T cells to promote disease exacerbations (Dakhama et 
al., 2013). The discrepancy in results could be due to the presence of different CD8 T cell 
subsets having different impacts on disease progression. Tc1 cells, protecting from viral 
infections, and IL-10 secreting CD8 cells, ameliorating pathogenic inflammation, are thought 
to be beneficial in the context of asthma. Tc2 and Tc9 cells on the other hand are considered 
detrimental, with IL-13 contributing to AHR and IL-9 and IL-4 supporting Th2 cell-driven 
inflammation (Baraldo et al., 2016). 
1.3.11 B cells 
B cells play an important role in the immune system by producing antibodies that bind to 
antigens with high specificity, leading to, depending on the antigen, neutralization or 
phagocytosis of pathogens and toxins. Binding of antibody to antigen can also lead to the 
activation of other effector cells mediated through Fc receptors. In the course of an immune 
response antibodies not only mature to gain higher specificity but B cells also undergo class 
switching in order to produce different classes of antibodies that are useful in different 
settings (Murphy and Weaver, 2016). IgE is the central antibody class relevant for allergic 
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disease. Mast cells and basophils are activated by crosslinking of IgE on the high affinity IgE 
receptor FcRI (Gould and Sutton, 2008; Lambrecht and Hammad, 2015). Blocking IgE with 
the antibody omalizumab reduces the number of FcRI and IgE expressing cells, as well as 
numbers of eosinophils, B cells and T cells at the site of inflammation in asthmatic patients 
(Holgate et al., 2005). 
Aside from their ability to produce antibodies, B cells also act as antigen presenting cells and 
are able to amplify Th2 cell responses in the HDM model (Dullaers et al., 2017; Wypych et 
al., 2018). IL-10-producing regulatory B cells have also been postulated to play a role 
(Floudas et al., 2016). Regulatory B cells from patients with allergic asthma produce less IL-
10 in response to LPS stimulation and have a reduced ability to induce IL-10 production in 
CD4 T cells (van der Vlugt et al., 2014). 
1.3.12 Mast cells 
Mast cells are thought to have originally evolved as a defense against parasitic worm 
infections but play an important role in the pathology of asthma. They can be activated by 
cross-linked IgE, or by complement components C3a and C5a. Activation triggers the release 
of cytosolic granules containing cytokines (IL-4, IL-5, IL-6, IL-13), histamine and serotonin, 
proteases and lipid mediators, such as leukotrienes, prostaglandins, sphingolipids and 
platelet-activating factor (Kubo, 2017). They also stimulate T cells by secretion of tumor 
necrosis factor (Nakae et al., 2006). However mast cells are not exclusively pathogenic in the 
context of allergic airway inflammation. IL-33 stimulated mast cells promote Treg cell 
expansion by the secretion of IL-2 and mice lacking mast cells have increased levels of 
airway inflammation after administration of papain (Morita et al., 2015). 
1.3.13 Basophils 
Basophils perform similar roles as mast cells, but basophils are short-lived compared to the 
longer life span of mast cells (Kiernan, 1979; Kubo, 2017; Ohnmacht and Voehringer, 2009). 
Basophils, as well as Th2 cells and eosinophils, express the chemokine receptor CCR3. They 
are recruited to the site of inflammation from the peripheral blood by the chemokine eotaxin 
(CCL11) (Uguccioni et al., 1997). Basophils are activated through the FcRI, C3aR and or 
C5aR similar to mast cells, followed by the release of granules containing a similar range of 
effector molecules as mast cells (Falcone et al., 2006). Secretion of IL-4 by basophils is 
required for ILC2-driven airway eosinophilia in response to protease allergens (Motomura et 
al., 2014). Basophils support type 2 responses and are able to aggravate airway inflammation 
(Wakahara et al., 2013) and it has been proposed that they are required for Th2 cell priming 
(Perrigoue et al., 2009). More recent studies however have demonstrated that they are not 
essential for the development of airway inflammation in the context of OVA administration 
(Ohnmacht et al., 2010) or for Th2 cell priming in a model using HDM allergens (Hammad et 
al., 2010). 
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1.3.14 Eosinophils 
Eosinophils are granulocytes that play a central role in host defense against multicellular 
parasites and in many types of asthma (McBrien and Menzies-Gow, 2017). They differentiate 
in the bone marrow, mediated by the cytokines IL-3, IL-5 and GM-CSF (Her et al., 1991) and 
are recruited to sites of inflammation by IL-5, IL-13, histamine, prostaglandin D2 and 
eotaxins (Fulkerson and Rothenberg, 2013). Eosinophils secrete cytokines promoting Th2 
cell responses, including IL-4 and release toxic granular proteins (Kita, 2013). IL-5 promotes 
release of granule proteins from eosinophils (Kita et al., 1992). This release can be gradual or 
immediate, through lysis of the cell (McBrien and Menzies-Gow, 2017). While eosinophils 
differentiate predominantly in the bone marrow, studies have shown precursors to be present 
in the blood of atopic patients and in bronchial biopsies of atopic asthma patients (Robinson 
et al., 1999; Sehmi et al., 1997). Eosinophil numbers correlate with severity of asthma and 
higher frequency of exacerbations (Bousquet et al., 1990; Price et al., 2015). Eosinophils 
secrete mediators promoting AHR, including IL-13 which can also induce goblet cell 
metaplasia (McBrien and Menzies-Gow, 2017). Antibody treatment against IL-5 significantly 
reduces the level of eosinophilia in asthmatic patients (Leckie et al., 2000).  
1.3.15 Neutrophils 
Neutrophils are short lived cells and among the earliest responders to any infected or 
wounded site. Up to 10
11
 neutrophils are produced in the bone marrow each day and they are 
the most abundant circulating leukocytes in humans (Summers et al., 2010). The central 
regulator of neutrophil development is granulocyte colony stimulating factor (G-CSF), 
controlling commitment to the myeloid lineage, proliferation and release of mature cells from 
the bone marrow (Lord et al., 1989; Richards et al., 2003). Neutrophils are easy to activate 
since they express every TLR except for TLR3 (Hayashi et al., 2003). The lifespan of 
neutrophils extends dramatically upon activation (Colotta et al., 1992). Neutrophils release a 
wide range of cytokines, including IL-1, IL-18, IFN-, IL-4, and BAFF (Mantovani et al., 
2011). They are also able to release intracellular and nuclear components, such as DNA, 
histones and enzymes from granules such as elastase. These structures are called neutrophil 
extracellular traps (Lee et al., 2017). Neutrophils are also able to produce and release reactive 
oxygen species. The abilities to both release potent inflammatory cytokines and cytotoxic 
substances taken together explain the severity of neutrophilic asthma (Ciepiela et al., 2015). 
Epithelial cells during wound healing release cytokines that enhance neutrophil recruitment 
and survival, with more infiltrating, longer lived neutrophils causing more tissue damage and 
healing this creates a positive feedback loop (Uddin et al., 2013). Even though neutrophils are 
associated with severe asthma, a recent study has shown that presence of neutrophils can limit 
ILC2 mediated airway inflammation by negatively regulating expression of G-CSF (Patel et 
al., 2019). 
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1.3.16 Innate lymphoid cells  
Innate lymphoid cells (ILC) lack TCRs but have been found to acquire functions akin to 
several T helper cell subsets. ILC1, ILC2, ILC3 and natural killer cells mirror Th1, Th2, 
Th17 cells and cytotoxic CD8 cells respectively. ILC1 are specialized producers of IFN-, 
ILC2 produce IL-4, IL-5 and IL-13, ILC3 produce IL-17 and IL-22 while NK cells are innate 
killers. As their names suggest, they are generally thought to act as a first line of defense prior 
to the initiation of adaptive immunity, and in some settings may also promote T cell 
responses (Halim et al., 2018). Increasingly, ILC2 are also implicated in the regulation of 
metabolic and tissue homeostasis in adipose tissue and in the gut (Lloyd and Snelgrove, 
2018; Moro et al., 2010; Vivier et al., 2018). Similar to Th2 cells, ILC2 respond to cytokines 
produced by the epithelium such as IL-25, IL-33 and TSLP (Ricardo-Gonzalez et al., 2018) 
and to prostaglandin D2 (Xue et al., 2014). ILC2 have been shown to be a major source of IL-
5 and IL-13 in mouse models using HDM or OVA (Wolterink et al., 2012), and there is 
evidence that ILC2 are increased in the blood and lungs of asthmatic individuals(Liu et al., 
2015). Protease allergens, such as papain, can induce AHR, mucus production and lung 
inflammation independently of an adaptive immune response, as was shown in Rag2
-/-
 mice 
lacking B and T cells. This inflammatory response is mediated by IL-33 and ILC2 (Kubo, 
2017; Oboki et al., 2010). Secretion of IL-13 by ILC2 disrupts tight junctions in the lung 
epithelia of both mice and humans. Epithelial barrier leakiness allows for higher penetration 
of allergens and microbes promoting inflammation and allergic responses (Sugita et al., 
2018). 
1.3.17 Allergen specific immunotherapy 
To date the only long-term cure for allergic disease is allergen-specific immunotherapy 
(AIT). The goal of AIT is to induce tolerance by administering low doses of allergens to 
patients over an extended period of time. The proposed mechanism is the shift of allergen-
specific effector T cells towards a regulatory phenotype, thereby suppressing DC-mediated 
activation of effector Th cell development, suppressing T helper cells directly, shifting the 
antibody balance from IgE towards IgG4 and suppressing eosinophil, mast cell and basophil 
activation (Akdis and Akdis, 2011). IgG4 has several properties that make it anti-
inflammatory, it has a lower affinity for certain Fc receptors and it does not activate the 
complement system (Aalberse and Schuurman, 2002; Meiler et al., 2008; Van der Neut 
Kolfschoten et al., 2007). There are several ways to administer AIT; either by subcutaneous 
immunotherapy (SCIT) or by sublingual immunotherapy (SLIT) or even intralymphatic 
delivery (Martínez-Gómez et al., 2009). While SCIT has been shown to be more effective, 
the risk for inducing systemic anaphylaxis is lower in SLIT (Dhami et al., 2017; James and 
Bernstein, 2017). AIT trials have had mixed success for different allergens. For example AIT 
trials for bee venom using T cell epitope peptides (Müller et al., 1998) and peanut allergies 
were successful (Fleischer et al., 2013), whereas other allergies have proven to be more 
difficult to treat with AIT. A recent review of 17 AIT trials for dog allergies reported on poor 
and conflicting results (Smith and Coop, 2016). AIT has also been tested for prophylactic 
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treatment of allergies. An AIT trial to prevent further sensitization in children with 
sensitization to one HDM allergen was successful (Pajno et al., 2001) whereas a trial 
targeting high-risk children has not been successful (Holt et al., 2013).  
Many AIT regimens rely on the use of natural extracts which have the advantage of being 
relatively easy to produce and contain known as well as unknown allergens, but depending on 
the supplier, allergen source and batch there can be significant differences between 
concentration of specific allergens (Wintersand et al., 2019). A few studies have been 
conducted using recombinant allergen proteins, which have the advantage of being less prone 
to contaminations and allow for more consistent allergen concentrations. This has been 
successful in a mouse model for cat allergies and for allergies against HDM (Haspeslagh et 
al., 2019; Neimert‐Andersson et al., 2008). 
1.4 T HELPER CELLS METABOLISM 
T helper cells require both energy and specific metabolites for biosynthesis pathways in order 
to proliferate and differentiate into functional effector cells (O'Neill et al., 2016). Naïve T 
cells use predominantly energy efficient metabolic pathways, that do not yield many side 
products such as the tricarboxylic acid (TCA) cycle and beta oxidation of fatty acids 
(MacIver et al., 2013). Naïve T cells however already accumulate untranslated mRNAs for 
genes required for glycolysis and fatty acid synthesis in order to be able to rapidly switch on 
these pathways upon activation (Ricciardi et al., 2018). Recently activated T cells turn on 
glycolysis as their main metabolic pathway. While glycolysis is not as energy-efficient, it 
provides the cells with acetyl-CoA for the TCA cycle, NADH and other intermediates to fuel 
biosynthesis of amino acids, nucleotides and fatty acids (Michalek et al., 2011). 
Differentiation and proliferation of T helper cells also require de novo synthesis of fatty acids 
(Lochner et al., 2015).  
Metabolism, cell growth and proliferation is centrally controlled by the kinase mammalian 
target of rapamycin (mTOR) (Saxton and Sabatini, 2017). Effector T helper cell subsets are 
dependent on mTOR complex1 (mTORc1), including the scaffold protein RAPTOR 
(regulatory associated protein of mTOR) (Yang et al., 2013). As well as mTORc1, Th2 cells 
also require mTORc2, containing the scaffold protein RICTOR (rapamycin-insensitive 
companion of mammalian target of rapamycin), as mTORc2 inhibits SOCS5 (suppressor of 
cytokine signaling-5), an inhibitor of STAT6 activation (Delgoffe et al., 2011; Seki et al., 
2002). Other targets of mTORc2, such as SGK1 and the GTPase RhoA have also been shown 
to promote Th2 cell function (Heikamp et al., 2014; Yang et al., 2016).  
Metabolism does not only provide cells with energy and the required metabolites for 
proliferation and the production of effector molecules, it also directly exerts control over 
effector functions. Active glycolysis is required for IFN- production. The glycolysis enzyme 
GAPDH binds to the 3’UTR of Ifng mRNA while glycolysis is inactive and thereby 
suppresses translation (Chang et al., 2013). De novo fatty acid synthesis is required for the 
development of Th17 cells and inhibition of the enzyme acetyl-CoA carboxylase 1 promotes 
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differentiation to Treg cells instead (Berod et al., 2014). CD5L shifts the lipidome of Th17 
cells towards polyunsaturated fatty acids and thereby controls the availability of lipid ligands 
for the master regulator of Th17 cells, RORt (Wang et al., 2015). The link between immune 
cell function and metabolism is of course not restricted to T cells and has been a recently 
growing field of interest for the study of various immune cells in different contexts (O'Neill et 
al., 2016). 
1.5 ANIMAL MODELS 
Mice do not spontaneously develop asthma, but administration of allergens and allergen 
extracts can be used to induce symptoms of allergic airway disease. For a long time, the 
model antigen ovalbumin (OVA) was used in combination with alum to induce OVA-specific 
Th2 cell-mediated responses. Mice sensitized to OVA were subsequently challenged through 
the airways with OVA and this was sufficient to induce several traits of allergic inflammation 
including airway eosinophilia, mucus secretion and AHR (Kumar et al., 2008). However, 
lacking in this approach were allergens themselves, which have enzymatic activity and 
activate the airway epithelium. In the past decade especially, a focus on using natural 
allergens has predominated studies of allergic airway inflammation. Several preclinical 
animal models using natural extracts or recombinant proteins of clinically relevant allergen 
sources have been developed, such as mouse models of house dust mite, cat or fungal 
allergies (Cates et al., 2004; Havaux et al., 2005; Neimert‐Andersson et al., 2008), as well as 
models for lupine and peanut food allergies (Andreassen et al., 2018; Burton et al., 2017). 
These have shown that the nature of the allergen can greatly affect the outcome of allergy 
(Lambrecht and Hammad, 2015; Nials and Uddin, 2008). Models using allergens including 
the protease papain, have been instrumental for studying the role of ILC in allergic airway 
inflammation (Halim et al., 2012; Halim et al., 2014). The advantage of mouse models is the 
availability of a large number of gene-targeted strains and the relative ease with which mice 
can be housed, bred and scaled up. Guinea pigs have also been used as animal models of 
asthma for over 60 years (Noelpp and Noelpp-Eschenhagen, 1952). Guinea pigs develop an 
early and a late asthmatic reaction and the lung is the primary target of anaphylaxis. 
However, less inbred strains and species specific reagents are available in guinea pigs 
compared to mice (Ricciardolo et al., 2008; Shin et al., 2009). Larger animals including 
horses and monkeys naturally develop allergic sensitivities, but are expensive and more 
difficult to handle and therefor are used less frequently than smaller laboratory animals (Shin 
et al., 2009). 
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2 AIMS 
The aim of my thesis was to better understand the factors regulating T helper cell 
differentiation in the context of allergic inflammation. 
Paper I investigated the role of PPAR-gamma in Th2 cell-mediated immunity using mice in 
which Pparg was specifically absent in T cells. 
Paper II assessed the plasticity and differentiation of T helper cells in the HDM model using 
single cell RNA-seq. 
Paper III developed a mouse model for allergic inflammation using dog allergens and 
explored the use of sublingual immunotherapy with recombinant dog allergens as a treatment 
option. 
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3 RESULTS AND DISCUSSION 
3.1 PAPER 1 
The incidence of asthma and allergic disease is increasing worldwide, requiring a better 
understanding of the underlying immune response (Moorman et al., 2012). A strong type 2 
immune response is essential for the protection from worm infection but is also a hallmark of 
many allergies. Type 2 responses are mediated by Th2 cells and ILC2 through the production 
of IL-4, IL-5 and IL-13 (Artis and Spits, 2015; Paul and Zhu, 2010). Central to the 
differentiation of Th2 cells is induction of the master regulator GATA-3 by signal transducer 
and activator of transcription 6 (STAT-6) (Paul and Zhu, 2010; Zheng and Flavell, 1997). 
GATA-3 not only promotes proliferation and expression of the Th2 cell effector cytokines, 
but also expression of the IL-33 receptor (IL-33R) composed of a common IL-1RAP chain 
and ST2 (Nawijn et al., 2001).  
We found that Pparg was upregulated in gene expression profiling of whole T helper cells 
from the lungs of mice after intranasal HDM administration. Several target genes of PPAR- 
also showed higher expression levels when compared to PBS-administered mice (Coquet et 
al., 2015b; Schneider et al., 2014). Cells from the lungs of mice after HDM sensitization and 
challenge were purified and divided into Th2 and Th17 cells based on the surrogate surface 
markers ST2 and CCR6 respectively, in order to determine which subset may express Pparg 
(Fig. 4A-D). Pparg was significantly more highly expressed in the sorted Th2 (ST2
+
) cells, 
where Il5 mRNA was also detected at high levels (Fig. 4B, 4C). Cells sorted from mesenteric 
lymph nodes (mesLN) of mice infected with the nematode Heligmosomoides polygyrus 
showed a similar pattern of expression (Fig. 4E-I), as did in vitro-generated T helper cell 
subsets. In vitro-generated Th2 cells from mice lacking one allele of Gata3 had significantly 
lower Pparg mRNA levels compared to cells from wild-type (WT) mice. This showed that 
PPAR- expression was specific for Th2 cells in multiple contexts. 
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We crossed mice with LoxP sites engineered into the Pparg gene with mice expressing the 
Lck-Cre transgene in order to explore the role of PPAR- in Th2 cell differentiation and 
function. Mice in which the Pparg gene was targeted for deletion in T cells will be referred to 
as Pparg
Lck
 and WT littermate control mice lacking the Lck-Cre transgene as Pparg
+
. 
Bronchoalveolar lavage (BAL) from Pparg
+
 and Pparg
Lck
 revealed similar levels of alveolar 
macrophages (Fig. 5A). In vitro-differentiated Th2 cells from Pparg
Lck
 had a 90% reduction 
in expression of Pparg mRNA compared to Pparg
+
 demonstrating almost complete deletion 
of Pparg in the CD4 T cell lineage (Fig. 5B). 
Mice were sensitized and challenged with HDM extracts to explore the role of PPAR- in 
vivo. Airway eosinophilia (Fig. 5C, 5D) and the number of airway-infiltrating T cells were 
reduced in Pparg
Lck
 compared to Pparg
+
 mice after HDM instillations, whereas the number 
of alveolar macrophages and neutrophils was not affected. Pparg
Lck
 mice lacked mucus-
secreting goblet cells in the airways, as determined by periodic acid-Schiff staining of lung 
sections, while Pparg
+
 mice showed goblet cell metaplasia after HDM sensitization and 
challenge. Lungs and mediastinal lymph nodes (medLN) had comparable numbers of 
CD4
+
CD44
+
 in Pparg
+
 and Pparg
Lck
 mice after HDM administration. However, these 
effector cells expressed lower levels of IL-5 and IL-13 in the lung in Pparg
Lck
 mice, while 
expression of IL-4 and IL-17 was not affected by the lack of Pparg expression in those cells. 
Production of Th2 cell cytokines in the medLN was similar between Pparg
Lck
 and Pparg
+
 
mice. This suggested that PPAR- was important for the development of IL-5+IL-13+ Th2 cell 
responses in the inflamed lung but not for the initial priming in the lymph node. 
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H. polygyrus-infected mice were used to explore whether lack of PPAR- had a similar effect 
on Th2 cell responses in parasite infections. Both Pparg
+
 and Pparg
Lck
 mice had increased 
numbers of total lymphocytes and effector CD4 T cells in the mesLN fifteen days after 
infection. Similar to what was observed in the HDM model, mice lacking Pparg expression 
in CD4 T cells had lower frequencies of IL-5
+
IL-13
+
 cells in the mesLN and lower 
frequencies of eosinophils. H. polygyrus-infected Pparg
Lck
 mice did not have reduced 
numbers of IL-4
+
 or IL-17
+
 T helper cells when compared to Pparg
+
 mice. Pparg
Lck
 mice 
had reduced serum levels of IgE after worm infection, further indicating an impaired type 2 
immune response. Worm burden after primary infection with H. polygyrus was similar 
between Pparg
+
 and Pparg
Lck
 mice, but when mice were dewormed two weeks after the first 
infection and reinfected one week later, Pparg
Lck
 mice had a significantly higher worm 
burden. Thus, Pparg was required for the differentiation of IL-5
+
IL-13
+
 Th2 cells and was 
required for protective immunity to H. polygyrus. 
The use of PPAR- agonists allowed us to explore the effect of PPAR- on Th2 cell effector 
functions. The prostaglandin derivative 15d12,14-PGJ2 (15d-PGJ2) was added to Th2 cell 
differentiation cultures. We did not observe an increase in IL-5 or IL-13 production, but 
expression of Il1rl1 (the gene encoding for ST2) was upregulated in cells exposed to 15d-
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PGJ2, and this was confirmed at the protein level by flow cytometry. A similar increase in 
ST2 expression could be induced with the synthetic PPAR- agonist pioglitazone (PIO). Both 
15d-PGJ2 and PIO could not increase the frequency of ST2 expression in Th2 cell 
differentiation cultures on cells from Pparg
Lck
 mice. The addition of PPAR- agonists could 
therefore be a way to increase the expression of ST2 on in vitro-differentiated Th2 cells, 
whose low expression in vitro has been recognized as a shortcoming of Th2 differentiation 
assays (Guo et al., 2009; Meisel et al., 2001). 
Next, we investigated whether lack of Pparg expression would lead to reduced ST2 levels in 
vivo. Effector CD4 T cells from the lungs of HDM-administered Pparg
Lck
 mice expressed 
less ST2 compared to Pparg
+
 mice. As described for IL-5 and IL-13 above, this difference 
could not be observed in effector cells from the medLN, further confirming the role of PPAR-
 in the development of a pathogenic Th2 cell response in the lung. Effector CD4 T cells from 
the mesLN and Peyer’s patches of H. polygyrus-infected PpargLck mice similarly showed 
less ST2 expression than cells from Pparg
+
 mice. Chimeric mice were created by injecting 
lethally irradiated congenic CD45.1
+
 mice 1:1 with bone marrow cells from WT 
(CD45.1
+
CD45.2
+
) and Pparg
Lck
 (CD45.2
+
) mice, in order to explore whether the 
requirement of PPAR- for Th2 cell responses was cell-intrinsic. When these mice were 
sensitized and challenged with HDM eight weeks after radiation and cell transfer, only a 
small proportion of Pparg
Lck
 effector CD4 T cells produced IL-5 and IL-13 in the lung 
compared to WT effectors. ST2 expression was also much lower in effector CD4 T cells from 
the Pparg
Lck
 fraction. In order to control for the effect of the Lck-Cre transgene alone, HDM 
was administered to Lck-Cre
+
Pparg
+/+
 and Lck-Cre
-
Pparg
+/+
 mice. There was no difference 
in levels of airway infiltrating eosinophils or expression of ST2 on effector CD4 T cells.  
We sorted CD4
+
CD44
+
ST2
+
 cells from lungs of Pparg
+
 and Pparg
Lck
 mice and performed 
whole-genome expression arrays, in order to better understand which genes may be regulated 
by PPAR-. Expression of master transcriptional regulators, such as Foxp3, Gata3, Bcl6, 
Tbx21 and Rorc, did not differ between both groups of mice. Analysis showed 29 genes to be 
differentially expressed by at least twofold between cells from Pparg
+
 and Pparg
Lck
 mice. 
These included genes known for their function in Th2 cell responses like Il5 and Il13 as well 
as known PPAR- target genes such as Chi3l3. The expression of several genes involved in 
metabolic processes such as carbohydrate synthesis (Galnt3), metabolite transport (Slc7a8) or 
lipid storage (Plin2) was increased in cells from Pparg
+
 mice while Tagap1 and Rras2, 
encoding for two small GTPases, were reduced. Increased expression of Galnt3 and Plin2 
from in vitro-generated Th2 cells could be observed when 15d-PGJ2 was added. PPAR- 
potentially supports Th2 cell function in the lung by promoting the expression of metabolic 
regulators. 
Visceral adipose tissue (VAT) contains populations of both CD4 T cells and ILC2 that have 
been proposed to play a role in the regulation of glucose metabolism (Cipolletta et al., 2012; 
Molofsky et al., 2013). Pparg mRNA could be detected in both CD4 T cells as well as ILC2 
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from the VAT albeit at lower levels than found in VAT macrophages. ILC2 from the VAT of 
Pparg
Lck
 mice did not have reduced levels of Pparg expression and were found at the same 
frequency as in the VAT of Pparg
+
 mice. Treg cells in the VAT have been described to 
express high levels of ST2 (Cipolletta et al., 2012). ST2 expressing CD4 T helper cells from 
both conventional Foxp3
-
 CD4 T helper cells and Treg cells from the VAT of Pparg
Lck
 mice 
were significantly reduced. CD4 T helper cells from the VAT of Pparg

 and Pparg
Lck
 mice 
were restimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin to assess the 
influence of PPAR- on cytokine production in these cells. Cells from PpargLck mice had a 
decrease in IL-5
+
 frequency but an increase in IFN-+ cells compare to cells from Pparg+ 
mice. IL-4, IL-5 and IL-10 have previously been described to promote glucose sensitivity and 
to mediate positive metabolic effects (Cipolletta et al., 2012; Wu et al., 2011). Contrary to 
that, we observed that Pparg
Lck
 mice gained less fat when aging and showed better control 
of glucose levels after overnight fasting. These findings indicate a potentially detrimental role 
of ST2
+
 Treg and Th2 cells for glucose sensitivity in aging animals, in line with recent studies 
on the effect of fat-resident Treg cells on age-associated insulin resistance (Bapat et al., 
2015). 
Paper I described an important role of PPAR- in the full effector differentiation of IL-5- and 
IL-13-expressing Th2 cells both in HDM-induced allergic airway inflammation and infection 
with the intestinal parasite H. polygyrus. PPAR- seemed to promote the expression of the IL-
33 receptor, which has been described to play an important role in the acquisition of Th2 cell-
specific functions , including secretion of IL-5 and IL-13 (Van Dyken et al., 2016). 
Furthermore PPAR- potentially influenced Th2 cell metabolism by regulating various 
metabolic genes. 
 
  
 24 
3.2 PAPER 2 
T helper cells play a central role in the development of asthma and allergic airway disease, 
with several subsets, such as Th2, Th9 and Th17 cells contributing to different types of 
disease (Koch et al., 2017; Lambrecht and Hammad, 2015). Single cell-RNA sequencing 
(scRNA-seq) allows for unbiased examination of gene expression at the single-cell level 
(Picelli et al., 2013), making it an excellent tool to study diverse populations of cells, which 
are difficult to sort by surface markers or which exhibit considerable plasticity, like T helper 
cells. In recent years several studies have employed scRNA-seq to study T helper cell 
responses in mouse models of malaria infection and multiple sclerosis (Gaublomme et al., 
2015; Lönnberg et al., 2017). 
We used the HDM model to induce allergic airway inflammation in mice and purified single 
CD3
+
CD4
+
CD44
+
 from the BAL. The BAL was chosen since cytokine-secreting cells are 
found in higher frequencies in this compartment, compared with the lung tissue and the 
medLN. Single cells were sorted into 384-well plates in two independent experiments and 
single-cell RNA sequencing (scRNA-seq) was performed using the SMART-Seq2 platform 
(Picelli et al., 2013). Out of the overall 12,000 genes that could be detected, 1,971 were 
variably expressed and six distinct clusters of T helper cells could be identified using 
unsupervised hierarchical clustering and visualization with t-distributed stochastic neighbor 
embedding (t-SNE) (Fig. 6A). Clusters were assigned to different types of T helper cells 
based on the overexpression of previously described key marker genes (Fig. 6B). We could 
thus identify clusters as Th2 (Il1rl1, Gata3, Il13,Il5) (Fig. 6C), Th1 (Cxcr3, Ccl5, Ms4a4b) 
and Treg (Foxp3, Ctla4, Il10) cells. No cluster could be identified as Th17 cells and 
expression of Il17a was weak, despite the detection of IL-17
+
 T helper cells after PMA 
stimulation. Pparg was highly enriched in Th2 cells, in line with Paper I and others 
describing PPAR- as having an important role for Th2 cell development and function 
(Angela et al., 2016; Chen et al., 2017; Nobs et al., 2017). We furthermore identified several 
genes as enriched in the Th2 cell cluster that have previously not been linked to Th2 cell 
biology, such as Igfbp7, Plac8, Gclc and many more (Fig. 6C). Thus scRNA-seq could be 
used to distinguish distinct clusters of T helper cells from the airways of mice administered 
HDM. 
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One of the clusters was found to be enriched for genes linked to the type-I interferon (IFN) 
response, including Ifit3, Isg15, Isg20, Mx1, Stat1 and Stat2. There was however no 
preferential expression of the type-I IFN receptors, indicating that cells in this cluster were 
not predisposed for a type-I IFN response. This response could be triggered by toll-like 
receptor (TLR) ligands in the allergen extract (Hammad et al., 2009). To test this, wild-type 
(WT), Tlr4
-/-
 and Myd88
-/-
 mice were sensitized and challenged with HDM and total lung 
CD4
+
 cells were sorted. Expression of Isg20 and Mx1 was assessed by qPCR. WT mice 
administered PBS and Myd88
-/-
 mice administered HDM expressed low levels of both genes 
compared to WT mice exposed to HDM. Tlr4
-/-
 mice had an intermediate phenotype, 
indicating that HDM possibly induces the production of type-I IFNs through TLR4 and other 
pattern recognition receptors. When mice were injected with an IFN- receptor blocking 
antibody, Mx1 gene expression in both sorted CD4
+
CD44
+
CD25
-
ST2
+
 or CD4
+
CD44
+
CD25
-
ST2
-
 cells was reduced. 
After showing that Th2 cells could be identified and studied by scRNA-seq in the airways on 
day 15, we used scRNA-Seq to study their differentiation at earlier time points. The 
production of Th2 cell cytokines was analyzed on day 0, 8, 10 and 15 in medLN and lung 
cells in order to determine the best time to purify cells for sequencing. Th2 cells could be 
detected by cytokine expression in small numbers in the lymph node at day 8 and increasing 
at day 10. Th2 cells became evident in the lung at day 10 and expanded further at day 15. ST2 
was chosen as a marker to enrich Th2 cells for scRNA-seq since a large percentage of Th2 
cytokine producing cells on day 10 in the medLN also expressed ST2. This was necessary 
since only a small proportion of T helper cells in the lung and medLN are Th2 cells. We 
sorted 200 CD4
+
CD44
+
CD25
-
ST2
+
 cells from medLN and 82 from lung on day 10. An 
additional 50 cells each of naïve CD4
+
 T and Treg cells from the medLN on day 0 were 
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purified. Six clusters and an additional seventh cluster containing proliferating cells could be 
identified from the single cell data set. It was evident that the transcriptional signature of cell 
clusters was associated with their tissue of origin and time-point. Treg cells could be 
identified in cells from naïve and day 10 medLN and from day 10 lung whereas naïve CD4
+
 
and Th2 cells were mostly found in single clusters. Cells with a type-I IFN signature again 
formed a separate cluster, containing both Treg and non-Treg cells, mostly from cells purified 
from the lung at day 10. Similar to Th2 cells from the airways on day 15, medLN Th2 cells 
on day 10 were enriched for Il4, Pparg, Igfbp7, Pdcd1 and Vdr. However, they were not 
enriched for Il13, in line with previous studies showing that IL-13 expression is only acquired 
after migration to the lung (Liang et al., 2012; Van Dyken et al., 2016). While stimulation of 
day 10 cells from the medLN was able to stimulate expression of IL-13, this might only be 
produced to a small extent under physiological conditions. 
We combined all single-cell data sets to probe Th2 cell differentiation over time. Clusters 
containing naïve, day 10 Th2 cells and day 15 Th2 cells were used for trajectory analysis by 
Scorpius (Cannoodt et al., 2016). Trajectory was defined from naïve cells passing through 
day 10 to day 15 Th2 cells and four gene expression modules could be identified. The first 
one contained genes whose expression was increased early in Th2 cell development and then 
maintained to day 15 such as Gata3and Nfkb1. The second module consisted of genes mainly 
expressed on day 15 Th2 cells (Ctla2a, Ahnak, Rbpj, Bhlhe40). The third and fourth modules 
were of genes expressed in naïve cells that were maintained at low levels (Pfn1, Gimap3) or 
not expressed at later time points (Lef1, Igfbp4). Il4 expression was higher in Th2 cells on 
day 10 than on day 15, implicating a stronger role for IL-4 in the lymph node than in the lung 
tissue. Another feature of day 10 cells was the expression of a set of genes associated with 
Tfh cells (Il6st, Tox, Cd200, Slamf6, Rilpl2, Plekho1) (Choi et al., 2015). However some 
canonical Tfh cell-associated genes, such as Bcl6 and Cxcr5 were not enriched in day 10 Th2 
cells. Flow cytometry confirmed the high expression level of Tfh cell-associated markers 
CD200, CD352, and ICOS and the low expression levels of CXCR5 and BCL6 of day 10 
Th2 cells. 
Several genes found to be enriched in Th2 cells by scRNA-seq were also confirmed by flow 
cytometric analysis of protein expression. Th2 cells from the lung and airways expressed 
CD200R1 and RANKL more frequently and had higher levels of PD-1 when compared to 
other cell subsets. Cells from the medLN showed a similar pattern, except for RANKL which 
was expressed on both Th2 and non-Th2 cells in similar frequencies. Cells were restimulated 
with PMA and cytokine expression was measured. IL-6 expression coincided with the 
expression of IL-5 and IL-13 but not with other cytokines. In the H. polygyrus model, 
CD200R1 and IL-6 were also found to be enriched in Th2 cells from the mesLN whereas PD-
1 and RANKL were not preferentially expressed on Th2 cells. We thus confirmed several 
targets found in the scRNA-seq dataset and showed organ- and model-specific expression 
patterns. 
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While scRNA-seq is an excellent tool to capture the gene expression of a single cell at the 
moment of analysis, it is limited in providing insights into the history of a cell and does not 
reveal other potential capabilities in gene expression. Analyzing chromatin status can reveal 
such features. Thus, we purified naïve cells from the medLN and Th2, non-Th2 and Treg 
cells from airway and lung combined of mice sensitized and challenged with HDM and 
performed assay for transposase-accessible chromatin using sequencing (ATAC-seq) 
(Buenrostro et al., 2015). Intervene (Khan and Mathelier, 2017) was used to gain a global 
understanding of the DNA accessibility. Over 50% out of 43,092 called peaks were 
specifically enriched in a single subset. Th2 cells showed accessibility at several regions 
across the Il4-Il13-Rad50 locus (Ansel et al., 2006), whereas non-Th2 and Treg cells were 
more accessible at the Ifng and Foxp3 loci respectively (Feng et al., 2014; Shih et al., 2016). 
Several genes identified by scRNA-seq as highly expressed in day 15 Th2 cells were found to 
be more accessible in sorted Th2 cells, including Vdr, Il6, Plac8, Cd200r1 and Igfbp7. 
ATAC-seq further allowed us to explore transcription factor (TF) binding sequences enriched 
in specific subsets using HOMER (Heinz et al., 2010). Th2 and Treg cell subsets were both 
enriched for motifs related to nuclear factor B (NF-B), AP-1, STAT and GATA3 activity. 
Th2 cells were specifically enriched for binding motifs for PU.1, IRFs, CEBP, Mef2d and 
PPAR-, whereas Treg cells were enriched for RORt and Nur77 motifs.  
By using Gene Ontology (GO) analysis (Consortium, 2017), molecular processes enriched in 
Th2 cells from the airways of HDM administered mice could be identified, including 
processes related to apoptosis, leukocyte differentiation, cytokine production as well as 
cellular metabolism to be enriched in Th2 cells. The Seahorse XF analyzer was used to probe 
the metabolic profile of in vitro-generated T helper cell subsets. It was necessary to use in 
vitro-differentiated cells, since these metabolic assays require a high number of cells which 
makes sorting cells from allergen-exposed mice not feasible. Th2 cells were the most 
glycolytic and had the highest rate of oxygen consumption compared to Th1and Treg cells. 
Previous studies (Chang et al., 2013) have described a role of glycolysis directly promoting 
the production of IFN-. To test the requirement for glycolysis in Th2 cells, cells were 
differentiated in vitro in medium containing glucose and glycolysis was either perturbed by 
the addition of 2-deoxy-D-glucose (2-DG) or by switching cells onto galactose for the last 
day of culture, which forces cells to use oxidative metabolism instead of glycolysis. Either 
intervention was able to greatly reduce IL-13 production compared to cells cultured in 
glucose. Gene set enrichment analysis (GSEA) of Th2 cells from the BAL of mice 
administered HDM did not identify genes involved with glucose metabolism to be especially 
enriched. Th2 cells were however enriched for the expression of genes involved in fatty acid 
oxidation and fatty acid synthesis. 
Fatty acid metabolism has been shown to be critical for ILC2 function (Wilhelm et al., 2016). 
The metabolic inhibitors 2-DG (blocks glycolysis), etomoxir (inhibits fatty acid oxidation) 
and orlistat (blocks fatty acid synthesis and uptake) were administered daily, starting on day 7 
(Fig. 7A)(Kridel et al., 2004; Padwal and Majumdar, 2007; Qu et al., 2016). Inhibition of any 
of these pathways led to a reduction in airway eosinophilia and numbers of airway-infiltrating 
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T cells when compared to control mice administered DMSO (Fig.7 A). Periodic acid-Schiff 
staining of lung sections and qPCR for Muc5ac mRNA showed that each drug was able to 
reduce the amount of mucus production and goblet cell metaplasia after HDM administration. 
Blocking of glycolysis had the strongest effect, reducing frequencies of Th1 and Th2 cells in 
the medLN and increasing the percentage of Treg cells in the airways (Fig. 7B). Impacting 
fatty acid metabolism had a strong effect in reducing Th2 frequencies, both in the airways 
and the lymph node, but not as strong as administration of 2-DG (Fig.7B). Total IgE levels 
were also impacted by blocking metabolic pathways, whereas allergen-specific IgG1 levels 
were not affected.  
 
In all, paper II used scRNA-seq to resolve the transcriptional profiles of naïve CD4
+
 T, Th1, 
Th2 and Treg cells as well as a population of responsive to type-I interferons from the 
airways of mice administered HDM. Expression of many genes was enriched in Th2 cells, 
including Il6, Cd200r1 and Plac8, which was further supported by analysis of chromatin 
accessibility. scRNA-seq performed at different time points revealed gene expression patterns 
during the development of Th2 cells. GSEA showed Th2 cells to be enriched for fatty acid 
metabolism and experiments with metabolic inhibitors could demonstrate that Th2 cell 
responses require both glycolysis and fatty acid metabolism. 
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3.3 PAPER 3 
The global incidence of asthma and allergic disease is rising (Moorman et al., 2012). Up to 
twelve percent of US citizens have been found to be sensitized to dog allergens and exposure 
to dogs has been estimated to cause over a million asthma attacks in sensitized patients per 
year in the US alone (Gergen et al., 2018). The only cure for allergic disease is allergen-
specific immunotherapy, where allergen is administered to patients in low doses over a long 
period of time with the goal of inducing tolerance (Akdis and Akdis, 2011). AIT for dog 
allergies has been attempted in several clinical trials with mixed results (Smith and Coop, 
2016). Unlike for many other sources of allergens like cat, house dust mite or peanuts, there 
is to this date no established mouse model for dog allergies (Burton et al., 2017; Cates et al., 
2004  Neimert‐Andersson et al., 2008). Such a model would be an important step towards 
achieving a better understanding of allergic responses to dog allergens and the development 
of therapies specific to dog allergy. We therefore aimed to establish a mouse model using 
inhaled dog allergen extracts, to characterize the immune response and to test sublingual 
administration of a recombinant allergen protein. 
We used a mix of dog dander and epithelial extracts for intranasal instillations in a similar 
regimen as was used in paper I and II (Fig. 8A). Mice sensitized and challenged with dog 
allergen extracts showed levels of airway infiltrating total cells (Fig. 8A), eosinophils (Fig. 
8C) and B cells comparable to the HDM model. Mice administered either PBS, HDM or dog 
allergen extracts had comparable numbers of alveolar macrophages (Fig. 8D). Administration 
of either HDM or dog allergen extracts induced goblet cell metaplasia. Dog allergen extracts 
however led to higher levels of T cells in the airways and a moderate increase of airway 
infiltrating neutrophils (Fig. 8A). Administration of dog allergen extracts also led to airway 
hyperresponsiveness when compared to PBS-administered mice. Inhalation of dog allergen 
extracts therefore induced similar levels of airway inflammation as HDM when used in a 
fifteen day model. 
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Rag1 knockout mice, lacking mature B and T cells, did not develop airway inflammation 
when exposed to dog allergen extracts which indicated that the observed airway inflammation 
was due to an adaptive immune response. Frequencies of T helper cells from the BAL of 
mice either administered HDM or dog allergen extracts producing Th2 cytokines or IFN- 
were similar, but mice exposed to dog allergen extracts showed significantly higher levels of 
IL-17 producing cells (Fig. 8F). The frequency of IL-17
+
 CD4 T cells was also higher in the 
lung of mice exposed to dog allergens (Fig. 8G). Since high levels of endotoxin in allergen 
extracts have been associated with stronger Th17 responses in mouse models (Zhao et al., 
2017), we tested the endotoxin content of the HDM and the dog allergen extracts. Both 
dander and epithelial extract were found to contain two orders of magnitude more endotoxin 
than the HDM extract. Th2 cells promote B cell class switching to IgG1 and IgE and serum 
from mice sensitized and challenged with dog allergen extracts had higher levels of allergen-
specific IgG1 and total levels of IgE when compared to mice administered PBS. Th17 cells 
promote the recruitment of neutrophils to sites of inflammation. The allergen administration 
regimen was modified by one additional instillation on day 15, three hours before sacrificing 
the mice since neutrophils are recruited rapidly to sites of inflammation. Mice challenged 
with this additional dose of dog allergen extracts showed a strong increase of airway 
infiltrating neutrophils when compared to HDM-administered mice. 
Lymph node cell cultures were used to assess specificity of cytokine production. Cells from 
mice administered either PBS alone, HDM or dog allergen extracts were stimulated with 
allergen extracts or recombinant Can f 1 or Can f 2 and cytokine production was quantified 
by a cytometric bead assay on the supernatant after two days of culture. Cells from mice 
challenged with either HDM or dog allergen extracts could be induced to produce IL-13, IL-5 
and IL-10 when stimulated with the respective allergen extract. Only stimulation of cells 
from mice exposed to dog allergens could induce production of IL-17 and IFN-. Dog 
allergen extracts induced low levels of cytokine production in cells from mice administered 
PBS or HDM, indicating involvement of an innate source of cytokine production. Both 
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recombinant allergens could stimulate cells from dog allergen exposed mice to produce IFN-
, but only Can f 1 could induce production of IL-5, IL-13 and IL-10. 
Th17 cells in allergy have been associated with adult-onset and steroid-resistant asthma 
(Domvri et al., 2018). We treated mice with dexamethasone to test whether corticosteroids 
could ameliorate the airway inflammation caused by dog allergen extracts. Mice received 
daily injections of dexamethasone starting on the first day of allergen challenge and one final 
dose of allergen extracts was administered three hours before sacrifice. Corticosteroid treated 
mice had lower levels of airway infiltrating eosinophils, B cells and T cells but the number of 
neutrophils in the airways was not significantly reduced. Numbers of both Th2- and Th17-
cytokine producing cells were reduced by dexamethasone injections.  
scRNA-Seq was used to further investigate the diversity of the T helper cell response to dog 
allergen extracts. CD3
+
 CD4
+
 cells from the BAL of mice sensitized and challenged with dog 
allergen extracts were sorted and analyzed using the droplet-based microfluidic system, 
Chromium (10X Genomics). We performed unsupervised hierarchical clustering and 
visualization using the Seurat pipeline and were able to identify 8 distinct clusters. Several 
clusters based on the expression of known marker genes, namely Th2, Th17, Treg and naïve 
cells were pinpointed. One cluster was enriched for genes associated with recently described 
CD4 CTL such as Ccl5, Gzmk, Ly6c2, Nkg7 and Tbx21. Notably this cluster was not 
specifically enriched for Ifng, which was expressed in many cell clusters. The Th17 cell 
cluster was enriched not only for known Th17 cell-associated genes such as Il17a, Ccr6 and 
Rorc but also for several genes like Aqp3, Ramp1 and Tmem176a which have only recently 
been linked to Th17 cell biology (Drujont et al., 2016; Mikami et al., 2012; Zhou et al., 
2016). The Th2 cell cluster was found to be enriched for several genes such as Plac8, 
Zcchc10, Cd200r1 and Il6 that were also found in Th2 cells in the HDM model in paper II. 
Further confirming our findings from paper II was also GO analysis showing that Th2 cells 
were enriched for genes involved with the regulation of apoptosis and lipid metabolism. We 
observed some gene expression overlap of Ifng, Il13 and Foxp3 with the Th17 cluster and 
confirmed the existence of IL-5
+
 IL-13
+
 IL-17
+
 triple positive and IL-17
+
 Foxp3
+
 or IL-17
+
 
IFN-+ double positive T helper cells by FACS. Thus scRNA-seq confirmed that dog allergen 
extracts cause a diverse response of T helper cells subsets including Th2 and Th17 cells. 
The analysis of TCR gene usage showed a diverse clonal response to dog allergen extracts. 
Correlation analysis showed the most clonal overlap between clusters 1-5 with a high 
frequency of clones shared between the Treg cluster and the other effector cell populations 
including Th2 and Th17 cells. This could be due to the generation of induced Treg cells 
(iTreg) from naïve cells or to the transdifferentiation of Treg cells into other subsets. Naïve 
cells had the least clonal overlap followed by the cluster showing characteristics of CD4 CTL 
indicating a distinct differentiation pathway for these cells. Thus TCR analysis reveals 
patterns of shared and restricted clonality between subsets of T helper cells infiltrating the 
lung after dog allergen extract administration. 
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We applied the dog allergen model to test prophylactic SLIT treatment using a recombinant 
protein called “necklace”, comprising Can f 1, Can f 2, Can f 4 and Can f 6 (Nilsson et al., 
2014a). Four weeks with three sublingual administrations of Necklace per week prior to 
allergen sensitization and challenge (Fig. 9A) was sufficient to reduce the number of airway 
infiltrating total cells (Fig. 9B), eosinophils (Fig. 9C), increase the number of Treg cells in the 
lung (Fig. 9E) and reduce the frequency of Th2-cytokine producing cells in the airways (Fig. 
9F). SLIT however could not reduce the proportion of IL-17 producing T helper cells and 
even increased the percentage of IFN-+ cells (Fig. 9F). Necklace SLIT did not reduce airway 
neutrophilia. Mice treated with Necklace showed reduced airway hyperresponsiveness and 
serum levels of total IgE were reduced while levels of dog allergen-specific IgG1 were 
increased.
 
Paper III showed that repeat inhalations of dog allergen extracts lead to airway inflammation 
in mice. This model produced a mixed Th2/Th17 cell response reminiscent of neutrophilic 
and adult-onset asthma. This study further demonstrated the potential use for SLIT using 
recombinant dog allergen proteins for treating dog allergen-induced airway inflammation. 
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3.4 FINAL REFLECTIONS AND FUTURE PERSPECTIVES 
This thesis provides insights into the diversity of T helper cells involved in allergic airway 
disease. The major findings are. 
 PPAR- expression is required for Th2 cells to properly differentiate into IL-5- and 
IL-13-producing cells in inflamed lung tissue and promotes the expression of the IL-
33 receptor on Th2 cells. 
 scRNA-seq of T helper cells in the HDM model of allergic airway inflammation 
reveals a population of T helper cells responding to type-I interferons, a distinct gene 
expression signature in Th2 cells and shows that Th2 cells in the airways are enriched 
for lipid metabolism genes. The use of metabolic inhibitors confirms that glucose and 
lipid metabolism is important for Th2 cell-mediated responses. 
 A novel mouse model for allergies to dogs shows a mixed Th2/Th17 cell response. 
scRNA-seq provides insights into the distinct gene expression profile of Th17, Th2 
and other T helper cell subsets in this model, including data showing shared clonality 
between Th2, Th17 and Treg cells. Amelioration of airway inflammation through 
SLIT demonstrates the potential use of recombinant dog allergen protein in AIT. 
Cell metabolism is important not only for energy generation and to enable cell replication, but 
also directly controls effector functions of immune cells. Papers I and II expand our 
knowledge of the metabolic processes governing Th2 cell responses. Since the publication of 
paper I, several others have reported on the central role of PPAR- for Th2 cell biology 
(Henriksson et al., 2019; Nobs et al., 2017). A recent study has shown that ILC2 in the 
context of allergic airway inflammation store lipid droplets in a process controlled by PPAR-
. This lipid storage and ILC2 function could be impaired by switching the mice to a 
ketogenic diet (Karagiannis et al., 2020). Plin2, a key mediator of lipid droplet formation, was 
down regulated in T helper cells lacking the Pparg gene, as shown in paper I, suggesting that 
PPAR- may serve a similar function in Th2 cells. Thus, with corroborating studies of a role 
for PPAR- in type 2 immunity, further consideration must be given to the impact that 
environmental factors may have on the development of allergy. PPAR- agonists are found in 
many foods and are common environmental pollutants (Carter et al., 2009; Grün and 
Blumberg, 2007). For instance, phthalates in polyvinyl chloride (PVC) plastics have known 
PPAR- agonist activity (Hurst and Waxman, 2003). This suggests that studies analyzing the 
impact of environmental PPAR- agonists on the development and severity of asthma might 
be worthwhile. 
Paper II shows that the production of Th2 cell cytokines is dependent on active glycolysis, 
similar to what has been described for the production of IFN- (Chang et al., 2013). Whether 
the effect on Th2 cells is also mediated through translational control by GAPDH or other 
glycolysis enzymes remains to be elucidated. While metabolic inhibitors and extreme dietary 
changes seem to have beneficial effects in mouse models of allergic airway inflammation, it 
remains to be seen whether those results can be replicated in patients and whether the 
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potential side effects on the rest of the immune system are worth the results. Targeting 
specific molecular processes could be a more realistic approach than inhibiting a whole 
pathway, but this will require further research. While still a fairly broad target, manipulation 
of mTORc2 signaling could be a more refined approach to affect Th2 cell metabolism and 
function. To find even more specific targets, studies more deeply investigating the 
metabolome of Th2 cells will be needed. 
One of the strengths of scRNA-seq is the ability to uncover novel target genes for several 
subsets of T helper cells at the same time. Paper II clearly identifies a gene expression profile 
for Th2 cells and pinpoints many genes that were not previously associated with Th2 cells. 
This gene list was largely confirmed by scRNA-seq data from the dog allergen extract model 
in paper III, where target genes and cellular processes found to be enriched in Th2 cells in the 
HDM model were also found to be enriched in this completely different allergen model. A 
recent study has shown genes, such as Bhlhe40, described in paper II to be of relevance in 
Th2 cells in a helminth infection model (Jarjour et al., 2020). These datasets now allow for 
the comparison of Th2 cells between different organs and disease models. Whether these 
target genes present an opportunity for novel therapies will require both gene expression data 
from allergic patients as well as mechanistic studies in mice.  
A population of T helper cells responding to type-I interferons as described in paper II has 
recently been reported in diverse tissues and contexts such as Alternaria alternata extract-
induced allergic airway inflammation (Gowthaman et al., 2019) or kidney infiltrates of lupus 
nephritis (Arazi et al., 2019). Interestingly we did not detect this population in the single-cell 
data set from the dog allergen-extract exposed mice, indicating that these different allergen 
extracts induce different microenvironments in the airways of exposed animals. Future 
studies will need to explore the function of these cells and their relevance for human 
pathologies. This could include studies employing conditional knockout mice lacking 
IFNAR1/2 receptors in order to determine the impact of type-I IFNs on Th2 cells. 
The mouse model of allergic airway inflammation induced by dog allergen extracts presented 
in paper III is a new model in which scientists can test Th2/Th17 cell-driven airway 
inflammation and therapies specific to dog allergy. Since analysis of allergen extracts showed 
high levels of endotoxin in the dog allergen extracts, we will need to explore the role of 
bacterial compounds in the extract further. We are aiming to test the effects of treating the 
dog allergen extracts with proteolytic enzymes prior to sensitizing and challenging mice, in 
order to elucidate the role of protein allergens and non-protein components in the extract.  
In this paper, we also show that prophylactic SLIT using recombinant dog allergen Can f 1, f 
2, f 4 and f 6 can be used to reduce airway inflammation induced by dog allergen extracts. 
Our results are in line with other studies showing that use of recombinant cat and HDM 
allergens can be used for AIT in mouse models (Haspeslagh et al., 2019; Senti et al., 2012). 
The use of recombinant proteins opposed to natural extracts for AIT has the advantage of 
being less prone to contaminations and fluctuations in concentrations of allergen proteins, 
which can differ greatly between suppliers and batches of natural extracts (Wintersand et al., 
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2019). Recombinant proteins further offer the possibility to modify the protein in ways to 
improve/alter the immune response (Senti et al., 2012) or to combine several allergen proteins 
in one recombinant protein as was done with “necklace” used in paper III. The next step will 
be to test whether SLIT using necklace can also be used to ameliorate disease after 
inflammation has already been established. While SLIT was able to reduce the Th2 cell 
response to dog allergen exposure, it did not reduce airway neutrophilia and frequency of 
Th17 cells. A paradox of our experiments was that we did not discern much IL-17 production 
in response to Can f 1 in restimulation cultures despite Can f 1 inducing Th2 and Th1 
cytokine production. Yet scRNA-Seq analysis showed high concordance in TCR usage 
between Th2 and Th17 cells and considerable Ifng expression by Th17 cells. It is possible 
that other allergens in the dog extracts are responsible for inducing Th17 cell differentiation 
and cytokine production, although this needs to be elucidated. These could be added to a 
future version of the “necklace” protein in an attempt to reduce the Th17 cell response. 
In conclusion, the work presented in this thesis sheds light on factors governing the 
differentiation and function of Th2 cells and the role of metabolism for Th2 cells. It 
showcases the power of scRNA-seq to uncover novel cell subsets and novel genes of interest 
for known populations. It further presents a novel mouse model using dog allergen extracts to 
induce a mixed Th2/Th17 cell response and demonstrates that prophylactic SLIT using 
recombinant dog allergen can ameliorate airway inflammation in mice. These findings 
improve on our understanding of T helper cell biology in the context of allergic airway 
inflammation and have implications for the development of future therapies. 
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